Platelet Aggregation and Endothelial Function in Patients with Complicated Essential Hypertension (Ischemic Stroke) and Coronary Heart Disease

被引:7
作者
Shimohina, N. Yu. [1 ]
Petrova, M. M. [1 ]
Savchenko, A. A. [1 ]
Smertina, E. G. [2 ]
Ionova, V. G. [1 ]
Tanashyan, M. M. [1 ]
机构
[1] VF Voino Yasenetskii Krasnoyarsk State Med Univ, Krasnoyarsk, Russia
[2] NS Karpovich Municipal Hosp 6, Krasnoyarsk, Russia
关键词
platelet aggregation; endothelial dysfunction; VON-WILLEBRAND-FACTOR; CARDIOVASCULAR-DISEASE; BLOOD;
D O I
10.1007/s10517-010-0864-9
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
In patients with complicated essential hypertension (ischemic stroke) and coronary heart disease, inductors of platelet aggregation in various doses induced "paradoxical" changes in platelet aggregation activity reflecting the degree of decompensation under conditions of persistent endothelial dysfunction. Aggregation inductors in low doses were shown to have a greater diagnostic significance. The content of endothelial dysfunction markers in the blood was persistently elevated under these conditions.
引用
收藏
页码:18 / 20
页数:3
相关论文
共 13 条
[1]  
BLANN A, 1993, BRIT J BIOMED SCI, V50, P125
[2]  
BURYACHKOVSKAYA LI, 2007, RUS MED ZH, V15, P290
[3]   Circulating markers of endothelial function in cardiovascular disease [J].
Constans, Joel ;
Conri, Claude .
CLINICA CHIMICA ACTA, 2006, 368 (1-2) :33-47
[4]  
FUNIAK S, 1995, J HUM HYPERTENS, V9, P705
[5]   RECEPTORS FOR ADP ON HUMAN BLOOD-PLATELETS [J].
HOURANI, SMO ;
HALL, DA .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1994, 15 (04) :103-108
[6]  
KLIMOVICH LG, 2004, TROMBOZ GEMOSTAZ REO, P37
[7]   A STUDY OF HEMOSTASIS IN ISCHEMIC CEREBROVASCULAR-DISEASE .1. ABNORMALITIES IN FACTOR-VIII AND ANTITHROMBIN [J].
METTINGER, KL .
THROMBOSIS RESEARCH, 1982, 26 (03) :183-192
[8]  
PETRISHCHEV NN, 2003, ENDOTHELIUM DYSFUNCT, P4
[9]   Von Willebrand factor, platelets and endothelial cell interactions [J].
Ruggeri, ZM .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (07) :1335-1342
[10]  
SCHACHINGER V, 2002, PANVASCULAR MED, P887